BioCentury
ARTICLE | Financial News

Aastrom amends follow-on

August 5, 2013 7:00 AM UTC

Aastrom Biosciences Inc. (NASDAQ:ASTM), Ann Arbor, Mich. Business: Gene/Cell therapy Date announced: 7/25/13 Type: Follow-on To be raised: Up to $15 million Shares: TBD Price prior: $0.37 Underwriter:...